Pilatus Biosciences, a biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, today announced the Company will present new preclinical ...
An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding ...
The manuscript presents important findings that advance our understanding of how microglia adapt their surveillance strategies during chronic neurodegeneration. The evidence presented is convincing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback